291 related articles for article (PubMed ID: 34053300)
1. 2021 Chitranjan S. Ranawat Award: Intraosseous vancomycin reduces periprosthetic joint infection in primary total knee arthroplasty at 90-day follow-up.
Park KJ; Chapleau J; Sullivan TC; Clyburn TA; Incavo SJ
Bone Joint J; 2021 Jun; 103-B(6 Supple A):13-17. PubMed ID: 34053300
[TBL] [Abstract][Full Text] [Related]
2. The John N. Insall Award: Higher Tissue Concentrations of Vancomycin Achieved With Intraosseous Regional Prophylaxis in Revision TKA: A Randomized Controlled Trial.
Young SW; Zhang M; Moore GA; Pitto RP; Clarke HD; Spangehl MJ
Clin Orthop Relat Res; 2018 Jan; 476(1):66-74. PubMed ID: 29529618
[TBL] [Abstract][Full Text] [Related]
3. [Intraosseous vancomycin in total knee arthroplasty].
Martínez WF; Tillet F; Bochatey EJ; Lopreite FA
Acta Ortop Mex; 2024; 38(3):172-178. PubMed ID: 38862147
[TBL] [Abstract][Full Text] [Related]
4. Intraosseous Regional Prophylactic Antibiotics Decrease the Risk of Prosthetic Joint Infection in Primary TKA: A Multicenter Study.
Parkinson B; McEwen P; Wilkinson M; Hazratwala K; Hellman J; Kan H; McLean A; Panwar Y; Doma K; Grant A
Clin Orthop Relat Res; 2021 Nov; 479(11):2504-2512. PubMed ID: 34397615
[TBL] [Abstract][Full Text] [Related]
5. The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial.
Chin SJ; Moore GA; Zhang M; Clarke HD; Spangehl MJ; Young SW
J Arthroplasty; 2018 Jul; 33(7S):S13-S18. PubMed ID: 29655497
[TBL] [Abstract][Full Text] [Related]
6. Intraosseous Regional Administration of Antibiotic Prophylaxis in Total Knee Arthroplasty.
Arthur JR; Bingham JS; Clarke HD; Spangehl MJ; Young SW
JBJS Essent Surg Tech; 2020; 10(4):. PubMed ID: 34055474
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome evaluation of intraosseous vancomycin in total knee arthroplasty.
Harper KD; Lambert BS; O'Dowd J; Sullivan T; Incavo SJ
Arthroplast Today; 2020 Jun; 6(2):220-223. PubMed ID: 32577466
[TBL] [Abstract][Full Text] [Related]
8. Intraosseous Vancomycin May Not Be Helpful in Aseptic Revision Knee Arthroplasty: A Single-Surgeon Consecutive Case Series.
Lachiewicz PF
J Arthroplasty; 2023 Jun; 38(6S):S281-S283. PubMed ID: 36738866
[TBL] [Abstract][Full Text] [Related]
9. Intraosseous Regional Administration of Vancomycin in Primary Total Knee Arthroplasty Does Not Increase the Risk of Vancomycin-Associated Complications.
Klasan A; Patel CK; Young SW
J Arthroplasty; 2021 May; 36(5):1633-1637. PubMed ID: 33468344
[TBL] [Abstract][Full Text] [Related]
10. Results of debridement, antibiotics, and implant retention for periprosthetic knee joint infection supplemented with the use of intraosseous antibiotics.
Kildow BJ; Patel SP; Otero JE; Fehring KA; Curtin BM; Springer BD; Fehring TK
Bone Joint J; 2021 Jun; 103-B(6 Supple A):185-190. PubMed ID: 34053280
[TBL] [Abstract][Full Text] [Related]
11. Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA.
Liu C; Kakis A; Nichols A; Ries MD; Vail TP; Bozic KJ
Clin Orthop Relat Res; 2014 Jan; 472(1):227-31. PubMed ID: 23645338
[TBL] [Abstract][Full Text] [Related]
12. Otto Aufranc Award: Intraosseous Vancomycin in Total Hip Arthroplasty - Superior Tissue Concentrations and Improved Efficiency.
Harper KD; Park KJ; Brozovich AA; Sullivan TC; Serpelloni S; Taraballi F; Incavo SJ; Clyburn TA
J Arthroplasty; 2023 Jul; 38(7S):S11-S15. PubMed ID: 37088221
[TBL] [Abstract][Full Text] [Related]
13. Dual-Agent Antibiotic Prophylaxis Using a Single Preoperative Vancomycin Dose Effectively Reduces Prosthetic Joint Infection Rates With Minimal Renal Toxicity Risk.
Burger JR; Hansen BJ; Leary EV; Aggarwal A; Keeney JA
J Arthroplasty; 2018 Jul; 33(7S):S213-S218. PubMed ID: 29656981
[TBL] [Abstract][Full Text] [Related]
14. Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review.
Wong MT; Sridharan SS; Davison EM; Ng R; Desy NM
Clin Orthop Relat Res; 2021 Aug; 479(8):1655-1664. PubMed ID: 33929342
[TBL] [Abstract][Full Text] [Related]
15. Intraosseous Administration of Medications in Total Knee Arthroplasty: An Opportunity for Improved Outcomes and Superior Compliance.
Harper KD; Incavo SJ
JBJS Essent Surg Tech; 2024; 14(2):. PubMed ID: 38779408
[TBL] [Abstract][Full Text] [Related]
16. Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties.
Hanada M; Nishikino S; Hotta K; Furuhashi H; Hoshino H; Matsuyama Y
Knee Surg Sports Traumatol Arthrosc; 2019 Jul; 27(7):2322-2327. PubMed ID: 30968239
[TBL] [Abstract][Full Text] [Related]
17. No effect of vancomycin powder to prevent infection in primary total knee arthroplasty: a retrospective review of 976 cases.
Yavuz IA; Oken OF; Yildirim AO; Inci F; Ceyhan E; Gurhan U
Knee Surg Sports Traumatol Arthrosc; 2020 Sep; 28(9):3055-3060. PubMed ID: 31728604
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.
Kheir MM; Tan TL; Azboy I; Tan DD; Parvizi J
Clin Orthop Relat Res; 2017 Jul; 475(7):1767-1774. PubMed ID: 28401341
[TBL] [Abstract][Full Text] [Related]
19. Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA.
Young SW; Roberts T; Johnson S; Dalton JP; Coleman B; Wiles S
Clin Orthop Relat Res; 2015 Nov; 473(11):3573-84. PubMed ID: 26224291
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of tobramycin and vancomycin in primary total knee arthroplasty achieves minimum inhibitory concentrations for common bacteria causing acute prosthetic joint infection.
Lawrie CM; Jo S; Barrack T; Roper S; Wright RW; Nunley RM; Barrack RL
Bone Joint J; 2020 Jun; 102-B(6_Supple_A):163-169. PubMed ID: 32475280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
